London, United Kingdom, March 10, 2016 --(PR.com
)-- Mr Page will be presenting on Day One of the conference with his presentation entitled "Human dose predictions from in vitro data: Validation using clinical data." His session will deliver insight into: Human dose as an excellent multi-parameter metric for directing compound optimisation; validation of human dose prediction using in vitro data and highlights of areas which can most profitably be optimised for a given series.
Other key speakers on the agenda include: Roche, UCB Pharma, Genentech, Merck Serono, GSK, Lundbeck, Sanofi-Aventis, Takeda and many more…
To download the full agenda, please visit www.admet-event.com/prcom
Hosted over two days, ADMET 2016 aims to help attendees to:
• Discover application of PBPK to drug development in rare diseases
• Review the role of drug transporters in drug delivery to CNS diseases
• Learn about better models for understanding, predicting and avoiding drug induced liver injury
• Discuss in silico approaches to evidence-based mechanistic modelling
• Analyse early dose predictions – a valuable tool in risk assessment and optimisation of small molecules
For those interested in attending, there is currently an early bird offer available saving £300 off of the conference price which expires on the 31st of March.
ADMET 2016 is sponsored by Corning and Sekisui XenoTech.
For sponsorship enquiries, contact Alia Malick on +44 (0) 207 827 6168 or email@example.com.
For delegate enquiries, contact Matthew Apps on +44 (0) 207 827 6093 or firstname.lastname@example.org.
For media enquiries, contact Zoe Gale on +44 (0) 207 827 6132 or email@example.com.
11th annual ADMET conference and exhibition
13-14 June 2016
Contact e-mail: firstname.lastname@example.org
Contact tel: +44 (0) 207 827 6093
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk